Mesenchymal stem cells as a gene therapy carrier for treatment of fi brosarcoma

*Present address: Cancer Research Institue, Xiangya School of Medicine, Centeral South University University, 90 Xiangya Road, Changsha, Hunan, 410078, PR China. †Present address: Department of Cardiothoracic Surgery, Xiangya Second Hospital, Central South University, 139 Renmin Zhong Road, Changsha, Hunan, 410011, PR China. ‡Present Address: Department of Orthopadedics, The 2nd Hospital of Shangxi Medical University, Taiyuan, Shanxi 030001, PR China. Correspondence to: Professor Gang Li, The Li Ka Shing Institute of Health Sciences, Department of Orthopaedics and Traumatology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China. E-mail: gangli@ort.cuhk.edu.hk © 2009 ISCT DOI: 10.1080/14653240902960429 Mesenchymal stem cells as a gene therapy carrier for treatment of fi brosarcoma Juanjuan Xiang1*, Jingqun Tang1†, Chao Song1,2, Ziquan Yang1‡, David Graham Hirst3, Qiu-Jian Zheng4 and Gang Li1,2 1Centre for Cancer Research and Cell Biology, School of Medicine, Dentistry and Biomedical Sciences, Queen’s University Belfast, Belfast, UK, 2The Li Ka Shing Institute of Health Sciences, Department of Orthopaedics and Traumatology, Faculty of Medicine, The Chinese University of Hong Kong, Clinical Sciences Building, Prince of Wales Hospital, Shatin, Hong Kong, PR China, 3School of Pharmacy, Queen’s University Belfast, Belfast, UK, and 4Department of Orthopaedics and Traumatology, The People’s Hospital of Guangdong Province, Guangzhou, Guangdong Province, PR China

[1]  Gang Li,et al.  Survival of xenogeneic bone marrow-derived mesenchymal stem cells in a xeno-transplantation model , 2008 .

[2]  Jonas Jarvius,et al.  Endothelial Cell Migration in Stable Gradients of Vascular Endothelial Growth Factor A and Fibroblast Growth Factor 2 , 2008, Journal of Biological Chemistry.

[3]  C. Ware,et al.  The FASEB Journal • Research Communication , 2007 .

[4]  Xi Chen,et al.  Chondrogenic Differentiation Alters the Immunosuppressive Property of Bone Marrow‐Derived Mesenchymal Stem Cells, and the Effect Is Partially due to the Upregulated Expression of B7 Molecules , 2007, Stem cells.

[5]  C. Wan,et al.  Concise Review: Multipotent Mesenchymal Stromal Cells in Blood , 2007, Stem cells.

[6]  Koji Yoshimoto,et al.  Primary Glioblastomas Express Mesenchymal Stem-Like Properties , 2006, Molecular Cancer Research.

[7]  Uwe Mehlhorn,et al.  Basic Fibroblast Growth Factor Controls Migration in Human Mesenchymal Stem Cells , 2006, Stem cells.

[8]  G. Semenza,et al.  Expression of Vascular Endothelial Growth Factor Receptor 1 in Bone Marrow-derived Mesenchymal Cells Is Dependent on Hypoxia-inducible Factor 1* , 2006, Journal of Biological Chemistry.

[9]  M. Raffeld,et al.  Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma , 2006, The Journal of experimental medicine.

[10]  Gang Li,et al.  Systemic recruitment of osteoblastic cells in fracture healing , 2005, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[11]  Simon C Watkins,et al.  Epidermal growth factor receptor-transfected bone marrow stromal cells exhibit enhanced migratory response and therapeutic potential against murine brain tumors , 2005, Cancer Gene Therapy.

[12]  H. Vogel,et al.  Embryonic Stem Cell Immunogenicity Increases Upon Differentiation After Transplantation Into Ischemic Myocardium , 2005, Circulation.

[13]  Jane Worthington,et al.  Evaluation of a synthetic CArG promoter for nitric oxide synthase gene therapy of cancer , 2005, Gene Therapy.

[14]  M. Rojas,et al.  Bone marrow-derived mesenchymal stem cells in repair of the injured lung. , 2005, American journal of respiratory cell and molecular biology.

[15]  T. Blankenstein,et al.  Immunotherapy: target the stroma to hit the tumor. , 2005, Trends in molecular medicine.

[16]  M. Andreeff,et al.  Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. , 2005, Cancer research.

[17]  M. Andreeff,et al.  Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. , 2004, Journal of the National Cancer Institute.

[18]  Simon C Watkins,et al.  Nitric Oxide and Ionizing Radiation Synergistically Promote Apoptosis and Growth Inhibition of Cancer by Activating p53 , 2004, Cancer Research.

[19]  I. Bellantuono,et al.  A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. , 2004, Blood.

[20]  Jeremy J Mao,et al.  Mesenchymal stem cells: isolation and therapeutics. , 2004, Stem cells and development.

[21]  Giulio Gabbiani,et al.  The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. , 2004, The International journal of developmental biology.

[22]  T. Ratliff.  TGF-Beta Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia , 2004 .

[23]  H. Tsuda,et al.  Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model , 2004, Gene Therapy.

[24]  D. Hirst,et al.  Use of the radiation‐inducible WAF1 promoter to drive iNOS gene therapy as a novel anti‐cancer treatment , 2004, The journal of gene medicine.

[25]  F. Barry,et al.  Mesenchymal stem cells: clinical applications and biological characterization. , 2004, The international journal of biochemistry & cell biology.

[26]  Elizabeth Simpson,et al.  Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. , 2003, Blood.

[27]  G. Balian,et al.  Transplanted bone marrow cells localize to fracture callus in a mouse model , 2002, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[28]  M. Chopp,et al.  Ischemic cerebral tissue and MCP-1 enhance rat bone marrow stromal cell migration in interface culture. , 2002, Experimental hematology.

[29]  M. Andreeff,et al.  Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. , 2002, Cancer research.

[30]  C. Carlo-Stella,et al.  Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. , 2002, Blood.

[31]  Jane Worthington,et al.  Tumour cell radiosensitization using constitutive (CMV) and radiation inducible (WAF1) promoters to drive the iNOS gene: a novel suicide gene therapy , 2002, Gene Therapy.

[32]  T. A. Hewett,et al.  Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. , 2001, Experimental hematology.

[33]  N. Hynes,et al.  Tyrosine kinase signalling in breast cancer , 2000, Breast Cancer Research.

[34]  A. Nel,et al.  Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin. , 1999, Journal of immunology.

[35]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[36]  I. Fidler,et al.  Therapy of cancer metastasis by activation of the inducible nitric oxide synthase , 1998, Cancer and Metastasis Reviews.

[37]  S. Itoh,et al.  Transforming Growth Factor-β1 Upregulates Transcription of α3 Integrin Gene in Hepatocellular Carcinoma Cells Via Ets-transcription Factor-binding Motif in the Promoter Region , 2005, Clinical & Experimental Metastasis.

[38]  T. J. Poole,et al.  The role of FGF and VEGF in angioblast induction and migration during vascular development , 2001, Developmental dynamics : an official publication of the American Association of Anatomists.